CN103463003B - Racemosins A在制备治疗缺血性脑损伤药物中的应用 - Google Patents
Racemosins A在制备治疗缺血性脑损伤药物中的应用 Download PDFInfo
- Publication number
- CN103463003B CN103463003B CN201310470467.8A CN201310470467A CN103463003B CN 103463003 B CN103463003 B CN 103463003B CN 201310470467 A CN201310470467 A CN 201310470467A CN 103463003 B CN103463003 B CN 103463003B
- Authority
- CN
- China
- Prior art keywords
- racemosins
- brain injury
- application
- ischemic brain
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- QZUNAFWZEXJWGD-UHFFFAOYSA-N racemosin Natural products C1=CC(=O)OC2=C1C(OC)=C1C=CC(C)(C)OC1=C2OC QZUNAFWZEXJWGD-UHFFFAOYSA-N 0.000 title claims abstract description 24
- 230000000302 ischemic effect Effects 0.000 title claims abstract description 18
- 208000029028 brain injury Diseases 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000003814 drug Substances 0.000 title claims abstract description 11
- 150000001875 compounds Chemical class 0.000 claims description 11
- 230000000694 effects Effects 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 22
- 210000004556 brain Anatomy 0.000 description 16
- 210000001519 tissue Anatomy 0.000 description 10
- 206010008118 cerebral infarction Diseases 0.000 description 9
- 206010061216 Infarction Diseases 0.000 description 8
- 230000007574 infarction Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 6
- 230000002490 cerebral effect Effects 0.000 description 6
- 210000000269 carotid artery external Anatomy 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 210000004004 carotid artery internal Anatomy 0.000 description 4
- 210000003194 forelimb Anatomy 0.000 description 4
- 210000003657 middle cerebral artery Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 201000006474 Brain Ischemia Diseases 0.000 description 3
- 241001290352 Caulerpa racemosa Species 0.000 description 3
- 206010008120 Cerebral ischaemia Diseases 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 210000001168 carotid artery common Anatomy 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 2
- 229960002327 chloral hydrate Drugs 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- SVDVJBWDBYSQLO-UHFFFAOYSA-N 5-(4-hydroxy-3-methoxyphenyl)-5-phenylimidazolidine-2,4-dione Chemical compound C1=C(O)C(OC)=CC(C2(C(NC(=O)N2)=O)C=2C=CC=CC=2)=C1 SVDVJBWDBYSQLO-UHFFFAOYSA-N 0.000 description 1
- 206010000117 Abnormal behaviour Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 208000037823 Cerebral ischemia/reperfusion injury Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 241000218628 Ginkgo Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 101000937642 Homo sapiens Malonyl-CoA-acyl carrier protein transacylase, mitochondrial Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 102100027329 Malonyl-CoA-acyl carrier protein transacylase, mitochondrial Human genes 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010063837 Reperfusion injury Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 210000001638 cerebellum Anatomy 0.000 description 1
- 210000004298 cerebral vein Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 238000000556 factor analysis Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000007971 neurological deficit Effects 0.000 description 1
- 210000000956 olfactory bulb Anatomy 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- SBNFWQZLDJGRLK-UHFFFAOYSA-N phenothrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 SBNFWQZLDJGRLK-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 210000003582 temporal bone Anatomy 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
- 210000000216 zygoma Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310470467.8A CN103463003B (zh) | 2013-10-10 | 2013-10-10 | Racemosins A在制备治疗缺血性脑损伤药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310470467.8A CN103463003B (zh) | 2013-10-10 | 2013-10-10 | Racemosins A在制备治疗缺血性脑损伤药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103463003A CN103463003A (zh) | 2013-12-25 |
CN103463003B true CN103463003B (zh) | 2015-06-17 |
Family
ID=49788201
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310470467.8A Expired - Fee Related CN103463003B (zh) | 2013-10-10 | 2013-10-10 | Racemosins A在制备治疗缺血性脑损伤药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103463003B (zh) |
-
2013
- 2013-10-10 CN CN201310470467.8A patent/CN103463003B/zh not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
Racemosins A and B, two novel bisindole alkaloids from the green alga Caulerpa racemosa;Ding-quan Liu,et al.;《Fitoterapia》;20130824;第91卷;15-20 * |
吲哚生物碱药物;Yoshio Ban等;《国外医药.植物药分册》;19891231;第4卷(第2期);54-68 * |
Also Published As
Publication number | Publication date |
---|---|
CN103463003A (zh) | 2013-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102872048B (zh) | Gypensapogenin B在制备治疗缺血性脑损伤药物中的应用 | |
CN103705504B (zh) | Myrtucommuacetalone在治疗缺血性脑损伤药物中的应用 | |
CN103463003B (zh) | Racemosins A在制备治疗缺血性脑损伤药物中的应用 | |
CN105055409A (zh) | 一种治疗缺血性脑损伤药物及其应用 | |
CN103622963B (zh) | Trigolutesins A在治疗缺血性脑损伤药物中的应用 | |
CN103751181B (zh) | 一种化合物在治疗缺血性脑损伤药物中的应用 | |
CN103385887B (zh) | Houttuynoid C在制备治疗缺血性脑损伤药物中的应用 | |
CN103356666B (zh) | Houttuynoid A在制备治疗缺血性脑损伤药物中的应用 | |
CN103381179B (zh) | Houttuynoid D在制备治疗缺血性脑损伤药物中的应用 | |
CN103356644B (zh) | Chukrasone A在制备治疗缺血性脑损伤药物中的应用 | |
CN103381154B (zh) | Chukrasone B在制备治疗缺血性脑损伤药物中的应用 | |
CN103381174B (zh) | Houttuynoid E在制备治疗缺血性脑损伤药物中的应用 | |
CN106309454A (zh) | Friedolanostanes在制备治疗缺血性脑损伤药物中的应用 | |
CN105267213A (zh) | Lycojaponicumins B在制备治疗缺血性脑损伤药物中的应用 | |
CN105267199A (zh) | Hedyotol B在制备治疗缺血性脑损伤药物中的应用 | |
CN102885824B (zh) | Gypensapogenin A在治疗缺血性脑损伤药物中的应用 | |
CN105395547A (zh) | Leuconodine B在制备治疗缺血性脑损伤药物中的应用 | |
CN105412085A (zh) | Cathepsin L在制备治疗缺血性脑损伤药物中的应用 | |
CN103127088A (zh) | Eryngiolide A在治疗缺血性脑损伤药物中的应用 | |
CN107865837A (zh) | Isovitexin在制备治疗缺血性脑损伤药物中的应用 | |
CN103356551A (zh) | Sarcaboside B在治疗缺血性脑损伤药物中的应用 | |
CN103356526A (zh) | Sarcaboside A在治疗缺血性脑损伤药物中的应用 | |
CN106580952A (zh) | 一种治疗缺血性脑损伤药物及其应用 | |
CN103462994A (zh) | Neonectrolide A在制备治疗缺血性脑损伤药物中的应用 | |
CN101269062B (zh) | 马钱素在制备治疗心脑血管疾病的药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHENGZHOU BAIEN TRADING CO., LTD. Free format text: FORMER OWNER: YAN JIANSHAN Effective date: 20150518 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20150518 Address after: 312400 Zhejiang city of Shaoxing province Shengzhou city streets Lake Yan Gong Dian Bei Lu Xi Si Nong No. 6 Applicant after: SHENGZHOU BAIEN TRADE CO., LTD. Address before: 312365 Zhejiang province Shaoxing Sanyou Village Bridge Songxia town north of Shangyu City No. 91 Applicant before: Yan Jianshan |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20151119 Address after: 223400 33, Huaian Town, Huaian, Jiangsu Patentee after: Huaian Fenfa Electronic Co., Ltd. Address before: 312400 Zhejiang city of Shaoxing province Shengzhou city streets Lake Yan Gong Dian Bei Lu Xi Si Nong No. 6 Patentee before: SHENGZHOU BAIEN TRADE CO., LTD. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150617 Termination date: 20161010 |